This trial is active, not recruiting.

Condition acute myocardial infarction
Sponsor Royal Brompton & Harefield NHS Foundation Trust
Collaborator Medical Research Council
Start date December 2013
End date January 2017
Trial size 560 participants
Trial identifier NCT02261324, 2013LF001H


This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this can predict future cardiovascular events and death.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Mortality rate
time frame: 1 year

Secondary Outcomes

Occurrence of cardiovascular events
time frame: 1 and 5 years
Need for repeat revascularisation
time frame: 1 and 5 years
Health resource usage
time frame: 1 and 5 years
All-cause mortality
time frame: 5 years
Cardiovascular death
time frame: 1 and 5 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Any patient hospitalised with an acute myocardial infarction who has undergone primary percutaneous coronary intervention - Capacity to consent - Able to walk - Age over 18 years Exclusion Criteria: - Significant co-morbidities that would limit exercise capacity or make exercise unsafe (e.g. neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation)

Additional Information

Official title Is the Four Metre Gait Speed a Useful Outcome Measure in Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention?
Principal investigator William DC Man, FRCP PhD
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Royal Brompton & Harefield NHS Foundation Trust.